Tajikistan Medical Device Customs Control: Confiscation and Destruction of Non-compliant Products

1. Key takeaways

Border control in Tajikistan follows a clear logical chain: customs notification, verification by the supervisory authority, then confiscation and destruction of non-compliant goods. Article 26(4) of Law No. 1893 provides that the customs authorities of the Republic of Tajikistan inform the state supervisory authority for pharmaceutical activity of the importation and exportation of medicines and medical devices; Article 26(6) prohibits the importation of counterfeit medicines, medicines that do not meet the established requirements, and medicines and medical devices whose validity period has expired; Article 26(10) provides that medicines, medical devices and parapharmaceuticals imported into Tajikistan that do not meet the requirements of normative legal acts are subject to confiscation and destruction in accordance with the established procedure. GRZAN notes that confiscation and destruction are statutory consequences, not discretionary outcomes – the provision uses the word shall, not may.

2. Legal basis

3. Expert insights

Insight 1: The information flow design of Article 26(4) makes the border a sensor of the regulatory system. The provision requires customs to inform the supervisory authority of every import and export operation. The practical consequence is that the supervisory authority holds the import and export record of every batch and can cross-check it against the register under Article 17(8) and the batch quality certificates under Article 13(1). GRZAN recommends that companies complete a consistency check of the three documents before shipment; any inconsistency in a single element can surface at the border.

Insight 2: The import ban of Article 26(6) covers three categories, and failure to meet established requirements matters most for devices. The provision prohibits the importation of counterfeit medicines, medicines that do not meet the established requirements, and medicines and medical devices whose validity period has expired. Read together with Article 16(7) (quality requirements follow the documents on which the registration was based), the established requirements point to the quality specification documents and technical conditions accepted into the registration dossier. The implication is that the benchmark for border inspection is the documentation the company itself submitted at registration; self-imposed specifications that are too strict become an obstacle of the company’s own making.

Insight 3: Confiscation and destruction under Article 26(10) are statutory consequences. The provision uses the wording that the goods shall be confiscated and destroyed in accordance with the established procedure, which is a mandatory norm. GRZAN notes that once goods are found not to meet the requirements of normative legal acts, the company has no statutory option of return or release after rectification. This risk should be addressed in advance in logistics and contract design, not left to be handled at the border.

Insight 4: Article 27(3) and Article 26(10) form two distinct destruction scenarios. Article 27(3) addresses medicines and medical devices whose validity period has expired, with the destruction procedure determined by the Ministry of Health; Article 26(10) addresses imported products that do not meet the requirements of normative legal acts. The trigger scenarios differ: the former is natural expiry during domestic circulation, the latter is non-compliance at the border stage. Companies handling destruction should distinguish the two and apply the corresponding procedure to each.

Insight 5: Article 47(4) sets out the environmental liability of the destruction stage separately. The provision states that where damage to human health or the environment is caused by violating the destruction rules, the persons who committed the violation compensate for the damage. This provision echoes Article 1(16) (the definition of packaging includes protecting the environment from pollution), and together they form Tajikistan’s responsibility system for the environmental dimension of medical products. GRZAN recommends engaging destruction providers that meet Tajik environmental requirements and retaining disposal records.

4. Practical recommendations

1. Complete a three-document consistency check before shipment. Under Article 26(4), build a pre-shipment checklist verifying the consistency of the registration certificate (Article 17(6)), the batch quality certificate (Article 13(1)) and the validity period (Article 26(6)).
2. Set technical specifications at the registration stage with border feasibility in mind. Under Article 26(6) and Article 16(7), the border inspection benchmark is the quality documentation submitted at registration; assess batch-to-batch stability against the specifications when setting them.
3. Address confiscation risk in logistics and contracts in advance. Under Article 26(10), non-compliant goods are subject to confiscation and destruction, with no statutory option of return or rectification; define risk allocation and document responsibilities in trade terms and contract clauses.
4. Keep the two destruction procedures separate: domestic expiry and border non-compliance. Under Article 27(3) and Article 26(10), build the corresponding handling flows separately and request the respective procedure documents from the Ministry of Health.
5. Retain environmental disposal records at the destruction stage. Under Article 47(4) and Article 1(16), select destruction providers that meet Tajik environmental requirements and retain disposal records and environmental certificates.

5. Verification checklist

• □ Confirmed the customs notification mechanism of Article 26(4)
• □ Built a pre-shipment consistency checklist for registration certificate, batch quality certificate and validity period
• □ Assessed batch-to-batch feasibility of the registered technical specifications at the border (Article 26(6), Article 16(7))
• □ Addressed the confiscation risk of Article 26(10) and the allocation of liability in logistics and contracts in advance
• □ Distinguished the two procedures: destruction on domestic expiry (Article 27(3)) and destruction on border non-compliance (Article 26(10))
• □ Obtained the Ministry of Health documents for both destruction procedures
• □ Retained environmental disposal records at the destruction stage (Article 47(4), Article 1(16))

Regulatory information verified as of October 29, 2026.

In the Central Asian market, the core capabilities of GRZAN focus on three points. First, distinguishing the different legal positions of each market within the Eurasian Economic Union: Kazakhstan and Kyrgyzstan are full member states where a choice exists between a national pathway and a Union pathway; Uzbekistan is an observer state with only a national pathway; Tajikistan and Turkmenistan are outside the Union framework and must follow purely national procedures. Second, local authorised representative services: GRZAN can act as the statutory representative of manufacturers in the above countries, undertaking registration submission, regulatory communication and post-market reporting obligations. Third, quality system and testing support: GRZAN assists in establishing a quality management system conforming to ISO 13485 and connects clients with locally accredited laboratory resources.

For business inquiries: info@grzanglobal.com